Author:
Polli James E.,Yu Lawrence X.,Cook Jack A.,Amidon Gordon L.,Borchardt Ronald T.,Burnside Beth A.,Burton Philip S.,Chen Mei‐Ling,Conner Dale P.,Faustino Patrick J.,Hawi Amale A.,Hussain Ajaz S.,Joshi Hemant N.,Kwei Gloria,Lee Vincent H.L.,Lesko Lawrence J.,Lipper Robert A.,Loper Alice E.,Nerurkar Shriniwas G.,Polli Joseph W.,Sanvordeker Dilip R.,Taneja Rajneesh,Uppoor Ramana S.,Vattikonda Chandra S.,Wilding Ian,Zhang Guohua
Reference1 articles.
1. Guidance for industry, waiver of in vivo bioavailability and bioequivalence studies for immediate‐release solid oral dosage forms based on a biopharmaceutics classification system. August2000, CDER/FDA (http://www.fda.gov/cder/guidance/3618fnl.htm).
Cited by
99 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献